Ligand Pharmaceuticals Inc
NASDAQ:LGND

Watchlist Manager
Ligand Pharmaceuticals Inc Logo
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Watchlist
Price: 109.3 USD -4.82% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Ligand Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

LGND Price Targets Summary
Ligand Pharmaceuticals Inc

Wall Street analysts forecast LGND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LGND is 147.26 USD with a low forecast of 126.25 USD and a high forecast of 168 USD.

Lowest
Price Target
126.25 USD
16% Upside
Average
Price Target
147.26 USD
35% Upside
Highest
Price Target
168 USD
54% Upside
Ligand Pharmaceuticals Inc Competitors:
Price Targets
6855
Ascentage Pharma Group International
41% Upside
KRRO
Korro Bio Inc
577% Upside
UTHR
United Therapeutics Corp
29% Upside
GLPG
Galapagos NV
28% Upside
RXRX
Recursion Pharmaceuticals Inc
47% Upside
MNPR
Monopar Therapeutics Inc
70% Upside
300142
Walvax Biotechnology Co Ltd
5% Downside
4597
Solasia Pharma KK
53% Upside

Revenue
Forecast

Revenue Estimate
Ligand Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Ligand Pharmaceuticals Inc's revenue is 5%. The projected CAGR for the next 3 years is 17%.

5%
Past Growth
17%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Ligand Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Ligand Pharmaceuticals Inc's operating income is -8%. The projected CAGR for the next 3 years is 62%.

-8%
Past Growth
62%
Estimated Growth
Estimates Accuracy
-30%
Average Miss

Net Income
Forecast

Net Income Estimate
Ligand Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LGND's stock price target?
Price Target
147.26 USD

According to Wall Street analysts, the average 1-year price target for LGND is 147.26 USD with a low forecast of 126.25 USD and a high forecast of 168 USD.

What is Ligand Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Ligand Pharmaceuticals Inc's revenue is 5%. The projected CAGR for the next 3 years is 17%.

What is Ligand Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
62%

For the last 8 years the compound annual growth rate for Ligand Pharmaceuticals Inc's operating income is -8%. The projected CAGR for the next 3 years is 62%.

Back to Top